Background: In STEMI patients, the duration of action potential dispersion occurs between normal and ischemic tissue due to the lengthening of the refractory period, causing transmural dispersion of repolarization, which could be detected with Tp-Te interval prolongation on the electrocardiogram (ECG). Benefits of fibrinolytic therapy in patients with STEMI has been demonstrated, with reduced mortality significantly and improve coronary patency in order to increase myocardial perfusion. The goal of this study was to determine Tp-Te interval alteration in STEMI patients before and after the fibrinolytic therapy between successful fibrinolysis compared to failed fibrinolysis. Method: Cross-sectional study was conducted to collect ECG from medical records at Dr. Sardjito General Hospital in January-September 2016. STEMI patients with onset less than 12 hours whom reperfused with fibrinolytic therapy were registered. Tp-Te interval was measured before, soon after (0 minute), and 30 minutes after fibrinolysis with successful and failed results. The unpaired t-test analysis was used to compare Tp-Te interval alteration after fibrinolysis. Then, ΔTp-Te cut-off value was determined to find sensitivity and specificity based on ROC. Result: Among 84 patients enrolled in this study, 46 patients with successful fibrinolysis and 38 patients with failed fibrinolysis. Both of groups had Tp-Te interval prolongation before fibrinolysis, with mean value of 120.30 ± 13.02 ms in successful fibrinolysis group and 118.57 ± 15.24 ms in failed fibrinolysis group. In successful fibrinolysis group, Tp-Te interval reduced significantly with ΔTp-Te value of 17.55 ± 13.35 ms on 0 minute and 20.85 ± 15.62 ms on 30 minutes after fibrinolysis, while in failed fibrinolysis group there was not a decrease of Tp-Te interval with ΔTp-Te value of -0.77 ± 11.00 ms on 0 minute (p <0.001) and -1.53 ± 14.35 ms on 30 minutes after fibrinolysis (p <0.001). Cut-off value ΔTp-Te 20 ms had sensitivity 52.2% and specificity 94.7% based on ROC, with strong discriminator value of AUC (0.888). Conclusion: There was a greater reduction of Tp-Te interval in STEMI patients with successful fibrinolysis compared to failed fibrinolysis, so it may be used as a alternative parameter of successful fibrinolysis.
INTRODUCTION
Coronary artery disease (CAD) is still the number one cause of mortality worldwide, with more than 7 million deaths due to CAD each year, which represented 12.8% of all causes of death. 1 ST elevation acute myocardial infarction (STEMI) is a clinical syndrome, which is a spectrum of acute coronary syndrome (ACS), which is defined by the characteristic symptoms of myocardial ischemia related with ST segment elevation in electrocardiography (ECG) and afterward followed with myocardial necrosis.
Myocardial ischemia causes metabolic changes and ion exchange. This cellular processes will lengthen repolarization and shorten the action potential in myocardium ischemic area. This arrhythmia is the most common cause of death in STEMI patients. 3, 4 Several studies show a decrease in mortality due to STEMI, along with the increase use of reperfusion therapy, the availability of percutaneous coronary intervention (PCI) facilities, modernantithrombotic therapy and secondary prevention. 5 Benefits of fibrinolytic therapy in patients with STEMI has been demonstrated, with significant reduction of mortality by administration of fibrinolytic therapy.
6
Traditional variables that had been used to assess response to fibrinolytic therapy was still less precision. The aim of this study was to determine
Tp-Te interval alteration in STEMI patients before and after the fibrinolytic therapy between successful fibrinolysis compared to failed fibrinolysis.
METHODS
This is an analytic observational study with cross sectional method on two unpaired groups. Data were obtained retrospectively to 
Statistical Analysis
The data obtained will be analyzed using the software SPSS for Windows version 18.0. the value, expressed in delta, is used to find the limit value using receiver operator characteristics (ROC) curves then prepared a sensitivityspecificity curve to help determine the sensitivity and specificity of the limit value.
RESULT
In this study there were 84 patients enrolled and met the inclusion and exclusion 
